A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)

Clinical trial NCT07544862 · RECRUITING

Trial details

NCT number: NCT07544862
Sponsor: Chengdu Kangnuoxing Biopharma,Inc.
Status: RECRUITING
Study type: OBSERVATIONAL

Atopic Dermatitis (AD)

Start date: 2026-06-02
Primary completion: 2027-12-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.